retatrutide or ozempic for weight loss: Study shows 30% body weight loss Retatrutide (Reta) - Better Than

Higher-dose GLP-1 medications used for weight loss are typically meant to correct a metabolic problem , not necessarily be a lifelong high-dose solution

For patients in Connecticut considering medical weight loss, GLP-1 therapy, peptide-based care, or body-composition-focused treatment, the more important question is not who is talking about retatrutide

Theyre not recommended if you have: Gastroparesis or severe GI conditions A personal or family history of medullary thyroid carcinoma or MEN2 genetic syndrome A history of pancreatitis Pregnancy or are breastfeeding Diabetic retinopathy (risk of worsening with rapid glucose drops) Always share your full health history with your providertransparency is critical for safe recommendations

Minireview: the glucagons-like peptide

Example: A person may read about trial results and then see a vial promoted online

Consistency is critical